• OPEN AN ACCOUNT
Indian Indices
Nifty
22,502.00 35.90
(0.16%)
Sensex
74,005.94 88.91
( 0.12%)
Bank Nifty
48,199.50 83.85
( 0.17%)
Nifty IT
33,438.75 56.90
( 0.17%)
Global Indices
Nasdaq
16,685.97 -12.35
(-0.07%)
Dow Jones
40,003.59 134.21
(0.34%)
Hang Seng
19,636.22 82.61
(0.42%)
Nikkei 225
39,069.68 282.30
(0.73%)
Forex
USD-INR
83.47 0.01
(0.01%)
EUR-INR
90.76 0.22
(0.25%)
GBP-INR
105.79 0.36
(0.34%)
JPY-INR
0.54 0.00
(0.51%)

EQUITY - MARKET SCREENER

Lupin Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500257
INE326A01037
452.0701112
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
LUPIN
32.52
75652.24
EPS(TTM)
Face Value()
Div & Yield %
51.04
2
0.48
 

lupin ltd
Lupin consolidated net profit rises 52.33% in the March 2024 quarter
May 07,2024
Net profit of Lupin rose 52.33% to Rs 359.43 crore in the quarter ended March 2024 as against Rs 235.96 crore during the previous quarter ended March 2023. Sales rose 13.04% to Rs 4895.11 crore in the quarter ended March 2024 as against Rs 4330.30 crore during the previous quarter ended March 2023.

For the full year,net profit rose 345.15% to Rs 1914.48 crore in the year ended March 2024 as against Rs 430.08 crore during the previous year ended March 2023. Sales rose 20.81% to Rs 19656.34 crore in the year ended March 2024 as against Rs 16269.98 crore during the previous year ended March 2023.

ParticularsQuarter EndedYear Ended
 Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var.
Sales4895.114330.30 13 19656.3416269.98 21
OPM %20.3613.34 -19.3911.05 -
PBDT954.81522.49 83 3619.081597.18 127
PBT497.71258.50 93 2422.27716.49 238
NP359.43235.96 52 1914.48430.08 345